Ofloxacin Generics Uk (Ofloxacin)

Ofloxacin is a fluoroquinolone antibacterial that interferes with bacterial DNA replication, making it effective for several infection types.

• Urinary tract infection: eradicates susceptible bacteria, aiding resolution of uncomplicated cystitis and pyelonephritis.
• Respiratory tract infection: treats community‑acquired pneumonia and bronchitis exacerbations caused by sensitive organisms.
• Skin and soft‑tissue infection: clears cellulitis, abscesses, and wound infections when pathogens are susceptible.
• Prostatitis: penetrates prostatic tissue to eliminate bacteria in chronic bacterial prostatitis.
• Gonorrhea: offers an oral alternative for uncomplicated Neisseria gonorrhoeae infection when susceptibility is confirmed.

• Ofloxacin exerts its antibacterial activity by binding to the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV. Inhibition of these enzymes prevents the supercoiling and separation of DNA strands required for replication and transcription, leading to bactericidal effects against a broad range of Gram‑negative and some Gram‑positive organisms. The drug accumulates intracellularly, achieving concentrations that exceed the minimum inhibitory concentration for susceptible strains, and its activity is concentration‑dependent.

Ofloxacin may cause a range of adverse reactions, varying from mild to potentially serious.

Common Side Effects

• Nausea: mild gastrointestinal upset occurring in many patients.
• Diarrhea: loose stools that are usually self‑limiting.
• Headache: transient cranial discomfort.
• Dizziness or vertigo: sensation of light‑headedness or imbalance.

Serious or Rare Side Effects

• Tendon rupture or tendinopathy: especially Achilles tendon, may occur without warning.
• QT interval prolongation: can lead to cardiac arrhythmias in susceptible individuals.
• Severe allergic reactions: including Stevens‑Johnson syndrome, toxic epidermal necrolysis, or anaphylaxis.
• Clostridioides difficile‑associated colitis: severe intestinal inflammation following disruption of normal flora.

When prescribing Ofloxacin, clinicians should evaluate patient‑specific factors and follow safety guidelines to minimize risks.

• Assess renal function: adjust dose or avoid use in severe impairment to prevent drug accumulation.
• Review concomitant medications: avoid drugs that increase tendon injury risk or prolong QT interval.
• Monitor for hypersensitivity: discontinue immediately if rash, Stevens‑Johnson syndrome, or anaphylaxis develop.
• Caution in elderly patients: higher incidence of CNS effects such as confusion or seizures.
• Avoid in patients with known fluoroquinolone hypersensitivity: risk of severe allergic reactions.
• Store at ambient temperature: keep tablets below 25 °C in the original container, protected from moisture and light.

Ofloxacin interacts with several medicines; understanding the level of interaction helps guide safe co‑administration.

Major Interactions (Avoid)

• Concurrent systemic corticosteroids: increased risk of tendon rupture and musculoskeletal injury.
• Antacids or supplements containing aluminum, magnesium, calcium, or iron: markedly reduce Ofloxacin absorption.
• Co‑administration with other QT‑prolonging agents (e.g., quinidine, macrolides): may precipitate serious cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

• Warfarin: Ofloxacin can enhance anticoagulant effect; monitor INR and adjust dose as needed.
• Theophylline: plasma concentrations may rise, increasing risk of toxicity; observe for nausea, seizures, or cardiac effects.